RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2015-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Your saved research and appointment questionsView recorded trial and retraction changes
FOXG1 Syndrome: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Integrating molecular studies and clinical disease models to provide mechanistic insight into neurodevelopment: guidance from FOXG1 syndrome.
O'Shea Holly et al., Developmental biology (1 July 2026)
https://pubmed.ncbi.nlm.nih.gov/41997343/
- 2.
Non-coding structural variants disrupt FOXG1 transcriptional regulation in early neurodevelopment.
Hamerlinck Lisa et al., Nature communications (3 June 2026)
https://pubmed.ncbi.nlm.nih.gov/42236689/
- 3.
AAV-mediated neuronal expression of FOXG1 restores oligodendrocyte maturation, myelination, and hippocampal structure in mouse models of FOXG1 syndrome.
Park Jaein et al., bioRxiv : the preprint server for biology (5 December 2025)
https://pubmed.ncbi.nlm.nih.gov/41573856/
- 4.
Natural history of epilepsy in FOXG1 Syndrome.
Rhodes Caleb et al., Epilepsy research (1 December 2025)
https://pubmed.ncbi.nlm.nih.gov/40882535/
- 5.
Temporal lobe-predominant cortical dysplasia with mild cortical thickening in FOXG1 syndrome
Kei Yamada et al., Brain and Development Case Reports (27 November 2025)
https://doi.org/10.1016/j.bdcasr.2025.100119
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
FOXG1 Syndrome
FOXG1 syndrome is a rare genetic brain disorder caused by changes in the FOXG1 gene. It usually appears in the first months of life with poor head growth, severe developmental delay, little or no speech, seizures and involuntary movements. Feeding, sleep and reflux problems are common. Care is supportive and involves seizure medicines, therapies, and help with feeding and mobility.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
There is not much recent research on FOXG1 Syndrome, so this page includes research published since 2015. Most pages on RareWays start at 2020.
Most Recent Research
Neurodevelopment relies on precise coordination across molecular, cellular, and circuit-level processes. Conventional studies into neurodevelopmental gene function are primarily guided by tissue- or cell-type-specific expression patterns and inherent protein properties or domain interactions. Consideration of human disease conditions can greatly enhance our understanding of the mechanics underlying forebrain development. In this review, we demonstrate how to combine these approaches using FOXG1 Syndrome, a rare monogenic neurodevelopmental disorder, as an example. We first summarize the core clinical features of FOXG1 Syndrome, then integrate this information with cellular and behavioral analyses of Foxg1 mutant mouse models to elucidate FOXG1's roles in distinct developmental processes, including telencephalic patterning, progenitor maintenance, neuronal migration and maturation, excitatory-inhibitory balance, and myelination. Moreover, we describe the known molecular mechanisms of FOXG1 action beyond pure transcriptional regulation. Finally, we also demonstrate how the spectrum of FOXG1 variants identified in patients, including gene-dosage changes, protein-truncating variants, missense variants, and chromosomal rearrangements, has enabled targeted functional analyses, each providing unique investigational value. Together, we aim to convey how "bedside-to-bench" directed studies can be utilized to refine classical developmental frameworks, and reveal unanticipated gene functions beyond early development.
Common Questions
What is FOXG1 Syndrome?
FOXG1 syndrome is a rare genetic brain disorder caused by changes in the FOXG1 gene. It usually appears in the first months of life with poor head growth, severe developmental delay, little or no speech, seizures and involuntary movements. Feeding, sleep and reflux problems are common. Care is supportive and involves seizure medicines, therapies, and help with feeding and mobility.
How many clinical trials are available for FOXG1 Syndrome?
RareWays currently indexes 2 clinical trials for FOXG1 Syndrome. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for FOXG1 Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for FOXG1 Syndrome.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.